Antitumor Effects of a Novel Phenylbutyrate-based Histone Deacetylase Inhibitor, (S)-HDAC-42, in Prostate Cancer

Type: Retraction
Notice date: 5/1/2019 0:00
Journal: Clinical Cancer Research: An Official Journal of the American Association for Cancer Research
Publisher: American Association for Cancer Research
Notice DOI: 10.1158/1078-0432.ccr-19-0731
Original paper DOI: 10.1158/1078-0432.ccr-06-0429

Reasons